FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease.
Ornitz
David M
DM
Department of Molecular Biology and Pharmacology, Washington University Medical School, St. Louis, Missouri 63110, USA. dornitz@pcg.wustl.edu
Marie
Pierre J
PJ
D000818:Animals; D001846:Bone Development; D002454:Cell Differentiation; D020219:Chondrogenesis; D024043:Collagen Type II / Q000378:metabolism; D024121:Collagen Type X / Q000378:metabolism; D003398:Craniosynostoses / Q000235:genetics; D005097:Exostoses, Multiple Hereditary / Q000235:genetics; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D006801:Humans; D008954:Models, Biological; D008957:Models, Genetic; D009154:Mutation; D010012:Osteogenesis; D011505:Protein-Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3; D017468:Receptors, Fibroblast Growth Factor / Q000235:genetics; D015398:Signal Transduction; D014158:Transcription, Genetic
D024043:Collagen Type II; D024121:Collagen Type X; D017468:Receptors, Fibroblast Growth Factor; D005346:Fibroblast Growth Factors; C496365:FGFR3 protein, human; D011505:Protein-Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3